You have 9 free searches left this month | for more free features.

Polyradiculoneuropathy

Showing 101 - 125 of 132

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Inflammatory Demyelinating Polyneuropathy, Multifocal Motor Neuropathy Trial in Aarhus C, Copenhagen (Resistance

Completed
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Multifocal Motor Neuropathy
  • Resistance training
  • Aerobic training
  • Aarhus C, Denmark
  • +1 more
May 11, 2016

Crohn's Disease Trial in Japan (TA-650)

Completed
  • Crohn's Disease
  • Hokkaido, Japan
  • +3 more
Jan 15, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +252 more
Jun 20, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Alabaster, Alabama
  • +427 more
Jul 3, 2019

Chronic Inflammatory Demyelinating Polyneuropathy Trial in Osaka (NPB-01)

Completed
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Osaka, Japan
    Nihon Pharmaceutical Co., Ltd
Jan 17, 2016

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Worldwide (Immune Globulin IV (Human), 10%

Completed
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
  • Immune Globulin IV (Human), 10% Caprylate/Chromatography Purified
  • Albumin (Human) 25%, United States Pharmacopeia (USP)
  • New Haven, Connecticut
  • +31 more
Feb 23, 2016

Patients With Crohn's Disease (All Patients Investigation)

Completed
  • Crohn's Disease
    • Abiko, Japan
    • +1130 more
    Jun 1, 2018

    Cancer Trial in Australia, United States (GSK2118436, GSK1120212)

    Completed
    • Cancer
    • Los Angeles, California
    • +14 more
    Jun 25, 2019

    Moderate Risk of CVD Trial in Worldwide (Aspirin (Acetylsalicylic acid, BAYE4465), Placebo)

    Completed
    • Moderate Risk of CVD
    • Aspirin (Acetylsalicylic acid, BAYE4465)
    • Placebo
    • Birmingham, Alabama
    • +465 more
    Sep 26, 2018

    Atherosclerotic Cardiovascular Disease Trial in Worldwide (Alirocumab, Placebo, LMT)

    Completed
    • Atherosclerotic Cardiovascular Disease
    • Birmingham, Alabama
    • +1387 more
    Mar 15, 2019

    Immunoglobulin Dosage and Administration Form in CIDP and MMN

    Completed
    • Chronic Inflammatory Demyelinating Polyneuropathy
    • +2 more
    • Copenhagen, Denmark
      Department of Neurology, Rigshospitalet
    Sep 18, 2015

    Autoimmune Autonomic Ganglionopathy (AAG) Trial in United States (Double blinded IVIg, Double blinded Placebo, Single Blinded

    Completed
    • Autoimmune Autonomic Ganglionopathy (AAG)
    • Double blinded IVIg
    • +2 more
    • Bethesda, Maryland
    • +5 more
    Jun 2, 2017

    Idiopathic Pulmonary Fibrosis Trial in South San Francisco (pirfenidone)

    Completed
    • Idiopathic Pulmonary Fibrosis
    • South San Francisco, California
      Genentech, Inc.
    Feb 9, 2017

    Idiopathic Pulmonary Fibrosis Trial in Worldwide (Simtuzumab, Simtuzumab )

    Terminated
    • Idiopathic Pulmonary Fibrosis
    • Birmingham, Alabama
    • +174 more
    Apr 28, 2017

    Demyelinating Polyneuropathy Trial in France (Immunoglobulin perfusion, Prednisone)

    Completed
    • Demyelinating Polyneuropathy
    • Clermont-Ferrand, France
    • +10 more
    Sep 25, 2014

    Chronic Inflammatory Demyelinating Polyneuropathy Trial in Worldwide (10% liquid formulation of human immunoglobulin)

    Completed
    • Chronic Inflammatory Demyelinating Polyneuropathy
    • 10% liquid formulation of human immunoglobulin
    • Bruxelles, Belgium
    • +21 more
    Aug 27, 2013

    Venous Thromboembolism Trial in Worldwide (dabigatran etexilate 150 mg twice daily (BID), matching twice daily (BID))

    Completed
    • Venous Thromboembolism
    • dabigatran etexilate 150 mg twice daily (BID)
    • matching placebo twice daily (BID)
    • Birmingham, Alabama
    • +146 more
    Jun 17, 2014

    Parkinson Disease Trial in Japan (Pramipexole Immediate Release, Pramipexole Extended Release)

    Completed
    • Parkinson Disease
    • Pramipexole Immediate Release
    • Pramipexole Extended Release
    • Akashi, Hyogo, Japan
    • +18 more
    Jul 29, 2014

    Atrial Fibrillation Trial in Worldwide (dabigatran dose 1, dabigatran dose 2)

    Completed
    • Atrial Fibrillation
    • dabigatran dose 1
    • dabigatran dose 2
    • Birmingham, Alabama
    • +566 more
    Jun 3, 2014

    Pulmonary Disease, Chronic Obstructive Trial in Worldwide (tiotropium, )

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • Anniston, Alabama
    • +489 more
    May 15, 2014

    Human Immunodeficiency Virus Type 1 Trial (Etravirine (ETR), Nucleotide reverse transcriptase inhibitors (NRTIs), Protease

    Completed
    • Human Immunodeficiency Virus Type 1
    • Etravirine (ETR)
    • +3 more
    • (no location specified)
    Jun 10, 2013

    Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Aarhus (Subcutaneous immunoglobulin)

    Completed
    • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
    • Subcutaneous immunoglobulin
    • Aarhus, Denmark
      Aarhus University Hospital, Noerrebrogade, Department of Neurolo
    Nov 9, 2011

    Acute Inflammatory Demyelinating Polyradiculoneuropathy, Myasthenia Gravis, Stroke Trial in Jerusalem (Siemens magnetom

    Unknown status
    • Acute Inflammatory Demyelinating Polyradiculoneuropathy
    • +4 more
    • Siemens magnetom avanto1.5 Tesla, Siemens magnetom trio A Tim system 3 Tesla
    • Jerusalem, Israel
      Hadassah Medical Organization
    Nov 8, 2011

    Breast Cancer Trial in Worldwide (Zoledronic acid, Letrozole)

    Completed
    • Breast Cancer
    • Buenos Aires, Argentina
    • +48 more
    Mar 19, 2012